DFFN Insider Trading Activity and SEC Form 4 Filings
DFFN insider trading summary
No open-market insider purchases or sales of Diffusion Pharmaceuticals Inc. (DFFN) have been reported on SEC Form 4 in the past 12 months.
Latest DFFN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 13, 2021 | Jane H Hollingsworth | Director | Buy | $20K (32,786 @ $0.61) |
| Nov 17, 2020 | William Robert Elder | GC & Secretary | Buy | $3K (5,000 @ $0.63) |
| Nov 16, 2020 | Robert Joseph Cobuzzi Jr. | President & CEO | Buy | $9K (14,000 @ $0.66) |
| Nov 16, 2020 | William Robert Elder | GC & Secretary | Buy | $7K (10,000 @ $0.67) |
| Dec 28, 2016 | Mark T Giles | Director | Buy | $0 (290,580 @ $0.00) |
| Dec 15, 2016 | Mark T Giles | Director | Buy | $0 (512,109 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.